Heart Failure

 Novel, Subcutaneous Furosemide Formulation May Benefit Worsening Heart Failure

Novel, Subcutaneous Furosemide Formulation May Benefit Worsening Heart Failure

In outpatients with worsening heart failure, a novel, pH-neutral furosemide formulation seems to be safe and effective.

Acute Heart Failure Survival Trends With Mediterranean Diet

Acute Heart Failure Survival Trends With Mediterranean Diet

Adherence to the Mediterranean diet does not influence long-term mortality in patients with acute heart failure.

Plasma NT-proBNP Levels Vary By Race

Plasma NT-proBNP Levels Vary By Race

Black individuals have significantly lower levels of plasma N-terminal pro-B-type natriuretic peptide, than white individuals.

Clinical Review: Treating Iron Defiency Anemia in Heart Failure

Clinical Review: Treating Iron Defiency Anemia in Heart Failure

By

Case study on the best practices for treating iron deficiency in heart failure patients.

Risk for All-Cause Mortality in HFrEF With Abdominal Obesity

Risk for All-Cause Mortality in HFrEF With Abdominal Obesity

Abdominal obesity is associated with increased risk for all-cause mortality in patients with heart failure.

High-Dose Beta-Blockers Associated With Lower Mortality in HF, Diabetes

High-Dose Beta-Blockers Associated With Lower Mortality in HF, Diabetes

By

Patients with chronic heart failure and diabetes may have a greater reduction in mortality with higher beta-blocker doses.

Heart Failure Related to Methamphetamine Use: Possible New Epidemic?

Heart Failure Related to Methamphetamine Use: Possible New Epidemic?

Heart failure due to methamphetamine use is increasing in prevalence among US veterans.

Hospital Readmissions Reduction Program Decreases Heart Failure Readmissions

Hospital Readmissions Reduction Program Decreases Heart Failure Readmissions

The Hospital Readmissions Reduction Program (HRRP) is associated with a reduction in readmissions for patients with heart failure.

Heart Failure Risk May Be Reduced With a Plant-Based Diet

Heart Failure Risk May Be Reduced With a Plant-Based Diet

By

Incident heart failure hospitalizations were reduced with plant-based diets.

Role of Coffee Consumption in Heart Failure, Stroke Outcomes

Role of Coffee Consumption in Heart Failure, Stroke Outcomes

By

In addition to known risk factors, coffee consumption reduces the risk of poor outcomes in heart failure and stroke.

Long-Term Prognosis in Heart Failure Worse With Diabetes

Long-Term Prognosis in Heart Failure Worse With Diabetes

Long-term prognosis among patients with acute heart failure is worse in those who have diabetes than in those who do not.

Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure

Continuous Furosemide Infusion Superior to Bolus Furosemide in Heart Failure

By

Researchers compared different administrations of furosemide in patients with acute decompensated heart failure.

Heart Failure Outcomes Improved With TAVR or SAVR

Heart Failure Outcomes Improved With TAVR or SAVR

By

Patients with heart failure who received transcatheter aortic valve replacements saw decrease in aortic valve mean gradient.

HFrEF: Similar Effects With Below-Target and Target Enalapril Doses

HFrEF: Similar Effects With Below-Target and Target Enalapril Doses

By

A study examined whether patients with heart failure with reduced ejection fraction who do not tolerate a high enalapril dose may still benefit from lower doses.

Lower Heart Failure Risk With Moderate Alcohol Consumption

Lower Heart Failure Risk With Moderate Alcohol Consumption

Moderate alcohol consumption is associated with reduced risk of heart failure but not atrial fibrillation.

Acute Myocarditis Prognosis Linked to Late Gadolinium Enhancement in Cardiac MRI

Acute Myocarditis Prognosis Linked to Late Gadolinium Enhancement in Cardiac MRI

For patients with acute myocarditis with preserved left ventricular ejection fraction and for patients with suspected myocarditis, late gadolinium enhancement on cardiac MRI is associated with worse prognosis.

Type 2 Diabetes Risks in Heart Failure Can Be Stratified by Glycemic Control

Type 2 Diabetes Risks in Heart Failure Can Be Stratified by Glycemic Control

For patients with heart failure, the risks conferred by type 2 diabetes can be stratified by glycemic control and drug treatments

Acute Heart Failure Mortality Predicted by Emergency Department Risk Score

Acute Heart Failure Mortality Predicted by Emergency Department Risk Score

A risk score based on 13 independent risk factors can predict 30-day mortality in patients with acute heart failure admitted to the emergency department.

LV Diastolic Function Improved in Diabetes With Pioglitazone

LV Diastolic Function Improved in Diabetes With Pioglitazone

Pioglitazone improves whole-body and myocardial insulin sensitivity, left ventricular diastolic function, and systolic function in patients with type 2 diabetes.

Lower Afib Risk With AdaptivCRT vs Conventional Cardiac Resynchronization Therapy

Lower Afib Risk With AdaptivCRT vs Conventional Cardiac Resynchronization Therapy

By

Patients who received synchronized left ventricular pacing with the AdaptivCRT had a lower risk of developing atrial fibrillation compared with patients who received conventional cardiac resynchronization therapy.

Umbilical Cord Stem Cells Improve Left Ventricular Function in HFrEF

Umbilical Cord Stem Cells Improve Left Ventricular Function in HFrEF

Intravenous infusion of umbilical cord-derived mesenchymal stem cells is safe and effective for patients with heart failure and reduced ejection fraction.

Wireless Pulmonary Artery Sensor Safely Reduces Heart Failure Hospitalizations

Wireless Pulmonary Artery Sensor Safely Reduces Heart Failure Hospitalizations

Postmarketing adverse events related to the CardioMEMS HF System are infrequent, but can be serious.

Sacubitril/Valsartan Increases Physical Activity in Systolic Heart Failure

Sacubitril/Valsartan Increases Physical Activity in Systolic Heart Failure

By

Patients with systolic heart failure see physical benefits with sacubitril/valsartan.

Metabolically Healthy Obese Individuals Still at Higher Risk for CV Events

Metabolically Healthy Obese Individuals Still at Higher Risk for CV Events

Metabolically healthy obese individuals have increased risk of coronary heart disease, cerebrovascular disease than those of normal weight.

Heart Failure Outcomes Not Improved With NT-proBNP Treatment Strategy

Heart Failure Outcomes Not Improved With NT-proBNP Treatment Strategy

By

High-risk patients with heart failure and reduced ejection fraction did not benefit from an amino-terminal pro-B-type natriuretic peptide-guided treatment strategy compared with usual care.

SGLT2 vs DPP4 Medications Associated with Lower Heart Failure Hospitalizations in Type 2 Diabetes

SGLT2 vs DPP4 Medications Associated with Lower Heart Failure Hospitalizations in Type 2 Diabetes

By

Patients with type 2 diabetes who received sodium-glucose co-transporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors had a lower risk for heart failure hospitalizations.

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

By

Patients treated with zoledronic acid had a higher risk for atrial fibrillation and other arrhythmias as well as heart failure vs untreated patients.

Lower Extremity Edema in a Woman With Heart Failure: A Case Study

Lower Extremity Edema in a Woman With Heart Failure: A Case Study

By

A middle-aged woman recently diagnosed with diastolic left heart failure now has increasing fatigue and worsening lower extremity edema.

Greater Risk for Heart Failure, Arrhythmia With Androgen-Deprivation Therapy

Greater Risk for Heart Failure, Arrhythmia With Androgen-Deprivation Therapy

Use of androgen-deprivation therapy may increase the risk of certain cardiovascular conditions in men with prostate cancer.

Risk Perception Among Heart Failure Patients vs Doctors

Risk Perception Among Heart Failure Patients vs Doctors

Physicians consider the majority of ambulatory patients with advanced heart failure on medical therapy to be at high risk for transplant, left ventricular assist device placement, and death.

Sign Up for Free e-Newsletters